Sacral neuromodulation and botulinum toxin for overactive neurogenic bladder in children

被引:0
|
作者
Aubert, D. [1 ]
Galli, G. [1 ]
Ramella, B. [1 ]
Moro-Enemuwe, A. [1 ]
Fotso-Kamden, A. [1 ]
机构
[1] CHU St Jacques, Serv Chrurg Pediat, F-25000 Besancon, France
来源
PELVI-PERINEOLOGIE | 2007年 / 2卷 / 03期
关键词
paediatric urology; neurogenic bladder; sacral neuromodulation; botulinum toxin;
D O I
10.1007/s11608-007-0137-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Overactive bladder is a major cause of urinary tract damage in children with congenital neurogenic bladder. Anticholinergics and bladder augmentation are the standard treatments. S3 sacral neuromodulation (InterStim (R)) and botulinum toxin injection (Botox (R) 12 mg/kg or Dysport (R)) into the detrusor muscle have recently been shown to be effective in adults. In children, the use of these treatments is still uncommon but the first results are as promising as those in adults and no adverse effects have been reported. In France, there is a need for additionnal randomized, multicenter trials to confirm the benefits of these two procedures in paediatric urology.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 50 条
  • [41] Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System
    Bertapelle, Maria Paola
    Vottero, Mario
    Del Popolo, Giulio
    Mencarini, Marco
    Ostardo, Edoardo
    Spinelli, Michele
    Giannantoni, Antonella
    D'Ausilio, Anna
    WORLD JOURNAL OF UROLOGY, 2015, 33 (08) : 1109 - 1117
  • [42] The Role of Neuromodulation in Patients with Neurogenic Overactive Bladder
    Aaron H. Lay
    Anurag K. Das
    Current Urology Reports, 2012, 13 : 343 - 347
  • [43] Botulinum toxin into the trigone in neurogenic overactive bladder non responder to detrusor injection
    Spinelli, M.
    Citeri, M.
    Zanollo, L.
    Macrellino, E.
    Redaelli, T.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (05) : 734 - 734
  • [44] The Role of Neuromodulation in Patients with Neurogenic Overactive Bladder
    Lay, Aaron H.
    Das, Anurag K.
    CURRENT UROLOGY REPORTS, 2012, 13 (05) : 343 - 347
  • [45] Effectiveness and safety of sacral neuromodulation for neurogenic bladder
    Wei, ZengGang
    Zhang, Yong
    Hou, JianPing
    NEUROLOGICAL RESEARCH, 2023, 45 (06) : 520 - 529
  • [46] Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: A systematic literature review
    Game, Xavier
    Mouracade, Pascal
    Chartier-Kastler, Emmanuel
    Viehweger, Elke
    Moog, Raphael
    Amarenco, Gerard
    Denys, Pierre
    De Seze, Marianne
    Haab, Francois
    Karsenty, Gilles
    Kerdraon, Jacques
    Perrouin-Verbe, Brigitte
    Ruffion, Alain
    Soler, Jean-Marc
    Saussine, Christian
    JOURNAL OF PEDIATRIC UROLOGY, 2009, 5 (03) : 156 - 164
  • [47] THE COST-UTILITY OF SACRAL NEUROMODULATION VERSUS BOTULINUM TOXIN A FOR THE TREATMENT OF REFRACTORY IDIOPATHIC OVERACTIVE BLADDER (WITH URGENCY URINARY INCONTINENCE) IN SWEDEN
    Borisenko, O.
    Reimer, E.
    Colpan, Z.
    Petkovski, A.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S239 - S240
  • [48] Botulinum Toxin Injection for Overactive Bladder
    Kuo, Hann-Chorng
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 406 - 406
  • [49] Use of botulinum toxin in overactive bladder
    Corcos, Jacques
    Schurch, Brigitte
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (11) : 667 - 669
  • [50] Botulinum toxin in the treatment of overactive bladder
    Sacco, E.
    Paolillo, M.
    Totaro, A.
    Pinto, F.
    Volpe, A.
    Gardi, M.
    Bassi, P. F.
    UROLOGIA JOURNAL, 2008, 75 (01) : 4 - 13